Covid vaccines are a freaking miracle; can telehealth cut costs?

The pandemic has been catastrophic. But consider something that may have escaped you: You have witnessed a freaking miracle. ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

Why Covid-19 vaccines are a freaking miracle By Helen Branswell Mike Reddy for STAT Even with certain advantages, there was no guarantee the world would be where it is today — and many reasons to believe it wouldn't be. Read More STAT+: What we know — and still don't know — about whether telehealth can cut costs By Mohana Ravindranath Adobe Telehealth proponents expected the pandemic to net them a windfall of convincing evidence. That hasn't proven to be the case. Read More Opinion: Immunocompromised people need greater access to monoclonal antibodies By Luciana Borio and John P. Moore Ted S. Warren/AP The estimated 7 million Americans who are immunocompromised are especially vulnerable to Covid-19. Monoclonal antibodies may help them. Read More Sponsor content by STAT Events The STAT Breakthrough Science Summit At this March 31 event, executives, researchers, scientists, and investors will take the stage to discuss the technologies and procedures at the cutting edge of health and medicine. Get your ticket now to learn about the latest efforts to battle diseases and help patients. STAT+: No more waffling: Belgium discloses penalties for failing to report clinical trial results By Ed Silverman Molly Ferguson for STAT "Clear communication of clinical trial reporting rules can significantly drive sponsor compliance," said Till Bruckner of TranspariMED. Read More Opinion: Creating a promising pathway for faster access to new drugs — and a Califf confirmation By Peter J. Pitts Eugene Hoshiko/AP The proposed Promising Pathways Act would require the FDA to create a priority program to provisionally approve new drugs. Read More Opinion: Controlled studies ease worries of widespread long Covid in kids By Shelli Farhadian and Shira Doron John Moore/Getty Images Early on, the potential for long Covid in kids loomed large. But the science on long Covid in kids tells a different story. Read More Monday, February 14, 2022       1 Exchange Pl, Suite 201, Boston, MA 02109 ©2022, All Rights Reserved. I no longer wish to receive STAT emails Update Email Preferences | Contact Us | View In Browser